These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8682597

  • 1. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM, Curry PV, Bailey AE, Steare SE.
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
    Erlemeier HH, Kupper W, Lange S, Bleifeld W.
    Z Kardiol; 1986 Feb; 75 Suppl 3():112-4. PubMed ID: 3541415
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH.
    Ann Intern Med; 1994 Mar 01; 120(5):353-9. PubMed ID: 8093132
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L, Andresen D, Hennig A, Levenson B, Brüggemann T, Schröder R.
    J Clin Pharmacol; 1991 Jul 01; 31(7):636-40. PubMed ID: 1894759
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R, Aleixo AM, Adao M, Machado FP, Mendes M, Bruges G, Palos JL.
    Am J Cardiol; 1990 Jun 01; 65(20):1308-12. PubMed ID: 2188493
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N, Olsson G, Engvall J, Rosenqvist U, Nyberg G, Aberg A, Ulvenstam G, Uusitalo A, Keyriläinen O, Härkönen R.
    Drugs; 1987 Jun 01; 33 Suppl 4():118-21. PubMed ID: 2887419
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO.
    Can J Cardiol; 1991 Apr 01; 7(3):125-30. PubMed ID: 2044014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
    Thadani U, Bittar N.
    Am J Cardiol; 1992 Aug 01; 70(3):286-92. PubMed ID: 1632390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.